v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Equity Award Programs
Common stock
Common stock
Equity Award Programs
Common stock and additional paid-in capital
Common stock and additional paid-in capital
Equity Award Programs
Accumulated deficit
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2024     92.2          
Beginning balance at Dec. 31, 2024 $ 485       $ 1,617   $ (1,132) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)     13.6 0.1        
Issuance of common stock 142       142      
Stock-based compensation 16       16      
Net income (loss) (112)           (112)  
Ending balance (in shares) at Mar. 31, 2025     105.9          
Ending balance at Mar. 31, 2025 531       1,775   (1,244) 0
Beginning balance (in shares) at Dec. 31, 2024     92.2          
Beginning balance at Dec. 31, 2024 485       1,617   (1,132) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (112)              
Ending balance (in shares) at Jun. 30, 2025     106.4          
Ending balance at Jun. 30, 2025 549       1,793   (1,244) 0
Beginning balance (in shares) at Mar. 31, 2025     105.9          
Beginning balance at Mar. 31, 2025 531       1,775   (1,244) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)       0.5        
Issuance of common stock   $ 3       $ 3    
Stock-based compensation 15       15      
Net income (loss) 0              
Ending balance (in shares) at Jun. 30, 2025     106.4          
Ending balance at Jun. 30, 2025 $ 549       1,793   (1,244) 0
Beginning balance (in shares) at Dec. 31, 2025 125.3   125.3          
Beginning balance at Dec. 31, 2025 $ 631       2,116   (1,485) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)       0.2        
Issuance of common stock   3       3    
Stock-based compensation 19       19      
Other comprehensive loss (1)             (1)
Net income (loss) (128)           (128)  
Ending balance (in shares) at Mar. 31, 2026     125.5          
Ending balance at Mar. 31, 2026 $ 524       2,138   (1,613) (1)
Beginning balance (in shares) at Dec. 31, 2025 125.3   125.3          
Beginning balance at Dec. 31, 2025 $ 631       2,116   (1,485) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ (219)              
Ending balance (in shares) at Jun. 30, 2026 127.0   127.0          
Ending balance at Jun. 30, 2026 $ 464       2,169   (1,704) (1)
Beginning balance (in shares) at Mar. 31, 2026     125.5          
Beginning balance at Mar. 31, 2026 524       2,138   (1,613) (1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)       1.5        
Issuance of common stock   $ 16       $ 16    
Stock-based compensation 15       15      
Net income (loss) $ (91)           (91)  
Ending balance (in shares) at Jun. 30, 2026 127.0   127.0          
Ending balance at Jun. 30, 2026 $ 464       $ 2,169   $ (1,704) $ (1)